Gastrointestinal stromal tumors (GIST) are rare mesenchymal tumors and were among the first solid tumor types for which such a novel treatment (in this case imatinib) became available. The ...

Based on the insights into the mechanisms underlying sensitivity to TKIs, it is very likely that the number of treatment options for patients with GIST will expand. Before such novel treatment ...

This research not only categorizes GISTs into specific molecular subtypes but also identifies YLPM1, a potential tumor ...